Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-28

FDA Approved: MECLIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Meclizine Hydrochloride from Rising Pharma Holdings, Inc., updating the product's labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meclizine hydrochloride (Meclizine hydrochloride)

Snippet

SUPPL AP for MECLIZINE HYDROCHLORIDE (MECLIZINE HYDROCHLORIDE)